Antigen Express, Inc. (Antigen)

Oncology Corporate Profile

HQ Location

Biotech 3, 4th floor
One Innovation Drive
Worcester, MA 1605

Company Description

Antigen Express is a platform technology and product-based company developing proprietary vaccine formulations for large, unmet medical needs. Our focus is on stimulating critical members of the immune response, known as CD4+ T helper cells. The technology allows for antigen-specific stimulation or suppression of a T-helper response to virtually any antigen of known pathogenic potential. Using this technology, Antigen Express is building a deep pipeline of therapeutics aimed at a variety of major diseases, including cancer, infectious diseases and autoimmune-based syndromes.

Website: http://antigenexpress.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
AE37immunotherapyBreast cancerII
AE37immunotherapyProstate cancerI
AE37immunotherapyAcute Myelogenous Leukemia (AML)Preclinical
AE37immunotherapyMelanomaPreclinical

View additional information on product candidates here »

Source: http://antigenexpress.com

Recent News Headlines

There are no news items to display